Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-04-05
2011-04-05
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S326000
Reexamination Certificate
active
07919465
ABSTRACT:
It is provided mimotope receptors and inhibitors that employ peptide mimics that mimic the shape and function of natural receptors and ligands, thus providing synthetic binding sites for ligands and receptors. Receptor mimics can be attached to carriers, such as liposomes, to act as synthetic platelets, for example, by providing multiple binding sites for binding to other (natural or synthetic) platelets or to the endothelium. Synthetic platelets would have virtually limitless shelf life and would not require disease screening prior to transfusion, thereby providing a solution to the perpetual platelet shortages, as well as the safety and storage issues associated with natural blood platelets.
REFERENCES:
patent: 4550163 (1985-10-01), Voss et al.
patent: 4833092 (1989-05-01), Geysen
patent: 5114842 (1992-05-01), Plow et al.
patent: 5238919 (1993-08-01), Zimmerman et al.
patent: 5321127 (1994-06-01), Handin
patent: 5328840 (1994-07-01), Coller
patent: 5336667 (1994-08-01), Kirby et al.
patent: 5428008 (1995-06-01), Chao et al.
patent: 5578565 (1996-11-01), Chao et al.
patent: 5679542 (1997-10-01), Scarborough
patent: 5817748 (1998-10-01), Miller et al.
patent: 5844098 (1998-12-01), Chao et al.
patent: 5877155 (1999-03-01), Miller et al.
patent: 5977313 (1999-11-01), Heath et al.
patent: 6008193 (1999-12-01), Garfinkel et al.
patent: 6139832 (2000-10-01), Li et al.
patent: 6177059 (2001-01-01), Matsuda et al.
patent: 6264988 (2001-07-01), Yen
patent: 6667032 (2003-12-01), Ni et al.
patent: 6706862 (2004-03-01), Hornik
patent: 6747135 (2004-06-01), Nolan et al.
patent: 6825319 (2004-11-01), Blank et al.
patent: 6858210 (2005-02-01), Marquis et al.
patent: 6926884 (2005-08-01), Ikeda et al.
patent: 6964769 (2005-11-01), Sebbel et al.
patent: 0255206 (1988-02-01), None
patent: WO 93/11778 (1993-06-01), None
patent: WO 93/16709 (1993-09-01), None
patent: WO 95/01375 (1995-01-01), None
patent: WO 00/56885 (2000-09-01), None
patent: WO 01/10911 (2001-02-01), None
patent: WO 02/063003 (2002-08-01), None
patent: WO 2004/062551 (2004-07-01), None
Wrighton et al., 1996, Small peptides as potent mimetics of the protein hormone erythropoietin, Science, 273: 458-464.
Del Caprio et al., 2002, Proteins: structure, function and genetics, 48: 696-732.
Brasseur, 1991, J Biol Chem, 266: 16120-16127.
Kohonen, 1990, Proceedings IEEE, 78: 1464-1480.
Del Caprio, 1996, Journal of Chemical Information and Computer Sciences, 36: 258-269.
Ponder and Case, 2003, Advances in Protein Chemistry, 66: 27-85.
Shimizu et al., 2004, J Biol Chem, 279: 16285-16294.
Hauert et al., 2004, ChemBioChem, 8: 856-864.
Xu et al., 1997, Protein Engineering, 10: 999-1012.
Cauwenberghs et al., 2000, Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates, Arterioscler Thromb Vasc Biol, 20: 1347-1353.
Kageyama et al., 2000, Anti-human von Willebrand factor monoclonal antibody AJvW-2 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs, Arterioscler Thromb Vasc Biol, 20: 2303-2308.
Staelens et al., 2006, Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain, J Biol Chem, 281: 2225-2231.
Yeh et al., 2001, Pharmacological characterization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist, J Pharmacol, 132: 843-850.
del Carpio Munoz et al., 2008, Rational design of antithrombotic peptides to target the von Willebrand Factor (vWf)-GPlb integrin interaction, J Mol Model, DOI 10.1007/s00894-008-0375-z.
Miller et al., 1996, Mimotope/Anti-mimotope probing of structural relationships in platelet glycoprotein Ibalpha, PNAS, 93: 3565-3569.
Campbell William
Constantinescu Iren
Del Carpio Munoz Carlos A.
Devine Dana V.
Gyongyossy-Issa Maria I. C.
Campbell William
Constantinescu Iren
Del Carpio Mundoz Carlos A.
Devine Dana V.
Gyongyossy-Issa Maria I. C.
LandOfFree
Peptide mimotopes that inhibits interaction between a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide mimotopes that inhibits interaction between a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide mimotopes that inhibits interaction between a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2696114